{"id":"https://genegraph.clinicalgenome.org/r/66f8e675-3370-494a-a646-c11f78a641c9v2.0","type":"EvidenceStrengthAssertion","dc:description":"The *TCAP* gene was first associated with hypertrophic cardiomyopathy (HCM) in 2004 with missense variants found in 2 probands (Hayashi et al, PMID 15582318). Three subsequent studies have identified missense variants in 6 probands (Bos et al, 2006, PMID 16352453; Andersen et al, 2009, PMID 19035361; Toste et al. 2020, PMID 32565061). None of these variants have functional evidence in support of pathogenicity. Furthermore, 1 variant (2 probands) is common in the population (Bos et al, 2006, PMID 16352453), and 2 co-occurred with other variants (pathogenic *TNNI3* variant, Andersen et al, 2009, PMID 19035361; VUS in *MYBPC3*, Bos et al. 2006, PMID 16352453).   The mechanism for disease is unknown. The gene-disease association is supported by expression data (Valle et al. 1997, PMID 9350988; Fagerberg et al. 2014, PMID 24309898, Uhlen et al. 2015, PMID:25613900) and an interaction with CSRP3 (Knoll et al. 2002, PMID 12507422; Vafiadaki et al. 2014, PMID 24860983)  which has moderate evidence for HCM. In summary, the evidence supporting the relationship between *TCAP *and HCM has been DISPUTED. More evidence is needed to either support or entirely refute the role *TCAP *plays in this disease.  This gene-disease relationship was originally  approved by the ClinGen Hypertrophic Cardiomyopathy Gene Curation Expert Panel on November 1, 2016. This gene-disease relationship was reevaluated on September 14, 2022 by the Hereditary Cardiovascular Disorders GCEP. As a result of this reevaluation, the classification changed from LIMITED to DISPUTED.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/66f8e675-3370-494a-a646-c11f78a641c9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b","calculatedEvidenceStrength":"Limited","changes":[{"id":"cg:summaryChange"},{"id":"cg:expertPanelChange"},{"id":"cg:sopChange"},{"id":"cg:newEvidence"},{"id":"cg:otherTextChange"},{"id":"cg:classificationChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2022-09-14T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2022-10-07T14:40:12.805Z","role":"Publisher"}],"curationReasonDescription":"Case reports are limited and none of these variants (mostly missense) reported have functional evidence in support of pathogenicity. Furthermore, 1 variant (2 probands) is common in the population (Bos et al, 2006, PMID 16352453), and 2 co-occurred with other variants (pathogenic TNNI3 variant, Andersen et al, 2009, PMID 19035361; VUS in MYBPC3, Bos et al. 2006, PMID 16352453). Finally, given that a timeframe of 6+ years has passed since the last gene-disease validity curation and no additional evidence to support the gene-disease relationship has been published, the group decided to modify the classification to dispute.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de248b5a-b4f2-4b20-9eea-bcbfcc4814d9","type":"EvidenceLine","dc:description":"Already scored Valle et al. PMID: 9350988 for RNA expression","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88ed5d45-b84e-4bee-8721-8f1b1a4489a5","type":"Finding","dc:description":"RNAseq transcriptomics study","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"RNAseq","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ce068c60-8d10-4142-9813-7977bbd0a111","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1aa37f7-870c-47b7-9205-77c03036338e","type":"Finding","dc:description":"Northern blot showed that TCAP expression is restricted to skeletal and heart muslces in human tissue. Antibody staining showed that TCAP expression overlaps with myosin and alternates with actin, typical expression of a sarcomeric protein.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9350988","rdfs:label":"TCAP Expression in Muscle","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/628fd188-fedd-4c8c-8076-7d2c3f0aa5af","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd524b40-635b-4402-89fa-b6413812f492","type":"Finding","dc:description":"Large scale proteomics study confirming protein expression in heart. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"Proteomics","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fece7904-dd59-465f-948a-c1cd47082bf2","type":"EvidenceLine","dc:description":"CSRP3 is a moderate evidence HCM gene. Discussed at panel meeting. Decision to score protein interaction for this gene. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0af3530-e9b1-46b1-b1d9-be1c0ea26353","type":"Finding","dc:description":"Y2H analysis and GST pull-down showed that TCAP interacts with CSRP3 (strongly associated with HCM) and further confirmed by colocalization via immunostaining in neonatal rat cadiomyocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12507422","rdfs:label":"CSRP3 Physical Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1afab8c0-f5f8-41b9-88a4-d04556244225","type":"EvidenceLine","dc:description":"Neither TTN nor CS-1 are strongly implicated in HCM.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf3d73d0-5d1b-4df5-acc8-5fa977938d09","type":"Finding","dc:description":"Y2H analysis and GST pull-down showed that two HCM mutations, T137I and R153H, augment TCAP's binding to titin and CS-1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15582318","rdfs:label":"TTN and CS-1 Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/274765e5-981b-4623-aa19-714e166ea9d2","type":"EvidenceLine","dc:description":"Protein interaction with CSRP3 already scored (Knoll et al.)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b57cdc8-23f5-4a94-b647-a2ee4665742e","type":"Finding","dc:description":"Another isoform encoded by CSRP3 (MLP-b) interacts with TCAP via GST pull-down","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24860983","rdfs:label":"CSRP3 Interaction Pull-Down","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82576764-f2fb-4ac6-a202-ea2b83e8b2c4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82576764-f2fb-4ac6-a202-ea2b83e8b2c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15582318","allele":{"id":"https://genegraph.clinicalgenome.org/r/78531496-d7ec-48f9-a944-c39ed04da07a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.410C>T (p.Thr137Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274680"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/82576764-f2fb-4ac6-a202-ea2b83e8b2c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Augmented protein interaction with TTN and MYOZ1 in this paper but neither are HCM genes. No augmented protein interaction with CSRP3 in this study. ","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c6e4d15e-30e9-40cc-86e6-bb3191f9f431","type":"EvidenceLine","dc:description":"Common variant. gnomAD 0.001. Clinvar x 15 B/LB\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6e4d15e-30e9-40cc-86e6-bb3191f9f431_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16352453","allele":{"id":"https://genegraph.clinicalgenome.org/r/292acd1d-69df-4ced-a854-47920f02aabc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.34_36GAG[1] (p.Glu13del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA134920"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0375b3bb-0bdb-4eb7-bbfa-3d30bd480040","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0375b3bb-0bdb-4eb7-bbfa-3d30bd480040_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32565061","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a205d41-6221-4f46-872b-72a471c55b34","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.171C>G (p.Cys57Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8532869"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c35abc20-c04c-49ec-af02-1bd270b0b50b_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f40f1e3-2a74-4c80-9362-ff1649a4db17","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f40f1e3-2a74-4c80-9362-ff1649a4db17_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","rdfs:label":"Walsh et al. ","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/0fc35f0d-0895-45b9-aee0-49ca41865d07","type":"Cohort","allGenotypedSequenced":6983,"alleleFrequency":0.2898467707289131,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f40f1e3-2a74-4c80-9362-ff1649a4db17_cc_evidence_item"}],"numWithVariant":2024},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/4e70696c-65e3-4bba-941f-a5a13ad45b33","type":"Cohort","allGenotypedSequenced":60706,"alleleFrequency":0.243896814153461,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f40f1e3-2a74-4c80-9362-ff1649a4db17_cc_evidence_item"}],"numWithVariant":14806},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/741789ce-ff38-4e2e-9d72-19931a2c2357","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/741789ce-ff38-4e2e-9d72-19931a2c2357_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396983","rdfs:label":"Lopes 2013","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/37f6613d-0f5a-499a-ab0b-6906a8186b12","type":"Cohort","allGenotypedSequenced":180,"alleleFrequency":0,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/741789ce-ff38-4e2e-9d72-19931a2c2357_cc_evidence_item"}],"numWithVariant":0,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/5fd8b470-e91e-420c-909b-fea2bb3bb104","type":"Cohort","allGenotypedSequenced":1278,"alleleFrequency":0.003912363067292645,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/741789ce-ff38-4e2e-9d72-19931a2c2357_cc_evidence_item"}],"numWithVariant":5},"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":1,"statisticalSignificanceType":"","statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d6d40379-e0f1-4377-86cd-e650a4e79cf2","type":"EvidenceLine","dc:description":"gnomAD 0.0000004. Clinvar x2 (VUS)\nHowever, pt also had MYBPC3 VUS p.Q998R. Discussed at GCEP meeting. Decision to reduce score due to MYBPC3 VUS. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6d40379-e0f1-4377-86cd-e650a4e79cf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16352453","allele":{"id":"https://genegraph.clinicalgenome.org/r/67ac6932-ca0c-46de-9fe3-5403f678ba96","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.269C>T (p.Pro90Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA181091"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0dfbe551-4589-4aa6-a58c-1a2b0d01922b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0dfbe551-4589-4aa6-a58c-1a2b0d01922b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15582318","allele":{"id":"https://genegraph.clinicalgenome.org/r/671b2f56-431b-4b38-91f5-6400a393f85c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.458G>A (p.Arg153His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA134926"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0dfbe551-4589-4aa6-a58c-1a2b0d01922b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Augmented protein interaction with TTN and MYOZ1 in this paper but neither are HCM genes. No augmented interaction with CSRP3 in this study. ","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/26d973c0-a485-4982-ba4b-f4f2abf0dc09","type":"EvidenceLine","dc:description":"Common variant. gnomAD 0.001. Clinvar x 15 B/LB\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26d973c0-a485-4982-ba4b-f4f2abf0dc09_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16352453","allele":{"id":"https://genegraph.clinicalgenome.org/r/292acd1d-69df-4ced-a854-47920f02aabc"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/35261bc1-80de-42aa-9273-5f3d885ec9be","type":"EvidenceLine","dc:description":"Common variant gnomAD 0.004 (NFE). Proband also had a class V variant in TNNI3\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35261bc1-80de-42aa-9273-5f3d885ec9be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19035361","allele":{"id":"https://genegraph.clinicalgenome.org/r/13f413c6-a709-4d49-a8c4-b6b7b60aee48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.316C>T (p.Arg106Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274805"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/06117b8a-5454-4fb4-9706-81afda957dc7","type":"EvidenceLine","dc:description":"gnomAD 0.00005. Clinvar x 7 (VUS","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06117b8a-5454-4fb4-9706-81afda957dc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16352453","allele":{"id":"https://genegraph.clinicalgenome.org/r/248c0c7d-0be5-478f-a88c-d18f11c16a39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003673.4(TCAP):c.208C>T (p.Arg70Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249987"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.4}],"evidenceStrength":"Disputed","sequence":5169,"specifiedBy":"GeneValidityCriteria9","strengthScore":1.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/aBmzdYkZPqI","type":"GeneValidityProposition","disease":"obo:MONDO_0005045","gene":"hgnc:11610","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c35abc20-c04c-49ec-af02-1bd270b0b50b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}